Skip to content

Half-effective volume study of 0.25% ropivacaine for supeior iliac fascia block of the inguinal ligament

Half-effective volume study of 0.25% ropivacaine for supeior iliac fascia block of the inguinal ligament

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065526
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip osteoarthritis and Hip fracture

Interventions

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective hip arthroplasty 2. BMI 18 to 28 kg/m2 3. ASA class I-III 4. No severe visual or hearing impairment 5. Age 16-80 years old

Exclusion criteria

Exclusion criteria: 1. Those with a history of psychiatric or neurological disorders or combined cranio-cerebral injuries that prevent normal communication 2. Preoperative patients who require continuous anticoagulation and/or antiplatelet drugs 3. Severe vital organ insufficiency 4. Patients with hearing impairment and aphasia 5. Infection at the puncture site 6. History of allergy to local anesthetics 7. Neuromuscular lesions of the lower extremities 8. History of epilepsy, alcoholism, and prohibited drugs 9. Patients who refuse to participate in the study or are unable to cooperate with the study (e.g., comorbid psychiatric disorders, language comprehension disorders, etc.)

Design outcomes

Primary

MeasureTime frame
Blocking plane;

Secondary

MeasureTime frame
Effective time;Maintaining time;

Countries

China

Contacts

Public ContactXin Zhao

The Second Hospital of Shandong University

lujnzx@sohu.com+86 17660085551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026